机译:Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
Univ Brescia;
ASST Spedali Civili;
migraine; CGRP; disability; burden; MIDAS; HIT-6; galcanezumab; GENE-RELATED PEPTIDE; ASSESSMENT MIDAS QUESTIONNAIRE; ATTACKS; IMPACT; ONABOTULINUMTOXINA; PHONOPHOBIA; RELIABILITY; SYMPTOMS; ANTIBODY; SAMPLE;